SEPAL PHARMA LTD.
2Patents
2Active
2Granted
40Portfolio score
Filing activity: Dec 7, 2006 → Sep 25, 2014 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9284252B2 | Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders | Chemistry; Metallurgy | 3 | Active |
| US8247439B2 | Jasmonate derivatives, pharmaceutical compositions and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.